JP2024504683A5 - - Google Patents
Info
- Publication number
- JP2024504683A5 JP2024504683A5 JP2023543339A JP2023543339A JP2024504683A5 JP 2024504683 A5 JP2024504683 A5 JP 2024504683A5 JP 2023543339 A JP2023543339 A JP 2023543339A JP 2023543339 A JP2023543339 A JP 2023543339A JP 2024504683 A5 JP2024504683 A5 JP 2024504683A5
- Authority
- JP
- Japan
- Prior art keywords
- tsg6
- pharmaceutical composition
- link
- once
- days
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2100761.2A GB202100761D0 (en) | 2021-01-20 | 2021-01-20 | Treatment of osteoarthritic pain |
| GB2100761.2 | 2021-01-20 | ||
| PCT/EP2022/051101 WO2022157181A1 (en) | 2021-01-20 | 2022-01-19 | Use of link-tsg6 for the treatment of osteoarthritic pain |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024504683A JP2024504683A (ja) | 2024-02-01 |
| JP2024504683A5 true JP2024504683A5 (enExample) | 2025-01-28 |
| JP7896251B2 JP7896251B2 (ja) | 2026-07-29 |
Family
ID=74679050
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023543339A Active JP7896251B2 (ja) | 2021-01-20 | 2022-01-19 | 骨関節炎痛の治療のためのｌｉｎｋ－ｔｓｇ６の使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250121028A1 (enExample) |
| EP (1) | EP4281098A1 (enExample) |
| JP (1) | JP7896251B2 (enExample) |
| KR (1) | KR20230142502A (enExample) |
| CN (1) | CN116744958A (enExample) |
| CA (1) | CA3204755A1 (enExample) |
| GB (1) | GB202100761D0 (enExample) |
| WO (1) | WO2022157181A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201910645D0 (en) | 2019-07-25 | 2019-09-11 | Univ Manchester | Treatment for dry eye disease |
| GB202416087D0 (en) | 2024-10-31 | 2024-12-18 | Link Biologics | Treatment of ocular disorders |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9878003B2 (en) * | 2006-03-06 | 2018-01-30 | The University Of Manchester | Method of treating bone disorders using TSG-6 |
| CN104703146B (zh) | 2013-12-09 | 2019-03-08 | 腾讯科技（深圳）有限公司 | 信息推送方法、客户端及系统 |
-
2021
- 2021-01-20 GB GBGB2100761.2A patent/GB202100761D0/en not_active Ceased
-
2022
- 2022-01-19 US US18/262,113 patent/US20250121028A1/en active Pending
- 2022-01-19 KR KR1020237027132A patent/KR20230142502A/ko active Pending
- 2022-01-19 JP JP2023543339A patent/JP7896251B2/ja active Active
- 2022-01-19 CN CN202280011039.6A patent/CN116744958A/zh active Pending
- 2022-01-19 EP EP22702634.1A patent/EP4281098A1/en active Pending
- 2022-01-19 CA CA3204755A patent/CA3204755A1/en active Pending
- 2022-01-19 WO PCT/EP2022/051101 patent/WO2022157181A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2471867C2 (ru) | Гиалуронидаза и способ ее применения | |
| JP4046388B2 (ja) | 亜鉛結合が増大したインシュリン誘導体 | |
| JPH08502074A (ja) | 組織の保護及び再生組成物 | |
| JP2004501101A5 (enExample) | ||
| BG100236A (en) | Sheared keratiocytic growth factor (kgf) of increased biological activity | |
| EP0433765A1 (en) | The use of immunomodulants as synergistic agents of chemotherapeutics in tumor therapy | |
| WO2003034996B1 (en) | Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment | |
| WO2021226485A3 (en) | Antisense therapeutics for betacoronavirus treatment | |
| US20110268696A1 (en) | Prevention and/or treatment of multiple organ dysfunction syndrome with interleukin-22 | |
| JP2002517247A (ja) | 亜鉛結合性が増大された新規なインスリン同族体 | |
| WO2003061728B1 (en) | Oral administration of interferon-tau | |
| JP2010503665A (ja) | 経口剤の形状でインスリンを作製する方法 | |
| RU2004114865A (ru) | Композиция и способ лечения диабета | |
| JPWO1999018993A1 (ja) | Ｃ型肝炎治療効果の改善剤及びその応用 | |
| KR100302994B1 (ko) | 약독화된비면역원성폭스바이러스또는파라폭스바이러스로부터멀티포텐트파라폭스면역유발인자의약제로서이용하는새로운적용 | |
| JP4070809B2 (ja) | インターフェロン−ガンマインヒビター含有医薬組成物 | |
| US20230322886A1 (en) | Recombinant protein comprising multiple multi-peptide sets, pharmaceutical composition comprising the recombinant protein, and method for preparing the recombinant protein | |
| JP2001526662A (ja) | 舌下投与式タブレットの製造のための水溶液におけるインターフェロンの安定化 | |
| US7781486B2 (en) | Punctual stimulation therapy | |
| CN113318222B (zh) | 超氧化物歧化酶在制备治疗银屑病药物中的应用及方法 | |
| IL312401A (en) | Methods for treating Crohn's disease with a specific anti-IL23 antibody | |
| JPH0995455A (ja) | 腎機能改善剤 | |
| JPS62252729A (ja) | 造血機能回復促進剤 | |
| EP0427633B1 (fr) | Utilisation d'un polypeptide ayant l'activité de l'interféron gammma pour la préparation de compositions pharmaceutiques destinées au traitement de cancers primitifs de la plèvre | |
| RU2233657C2 (ru) | Способ лечения красного плоского лишая |